Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:06:21.100Z.
Calculation as of: 2026-10-06T14:06:21.100Z.
Quote observation: 2026-10-06T14:05:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6dae1ed753b385efcb651dd8f32a10b6f9886011747f410ddce9f57bee9a14c9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Dianthus Therapeutics, Inc.
Market Cap
$4.80B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.86B
Operating Cash Flow Yield
N/A
TTM Avg
0.78%
3Y Avg
0.73%
5Y Avg
0.73%
Market Cap
$4.73B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.99B
Operating Cash Flow Yield
0.91%
TTM Avg
0.60%
3Y Avg
0.60%
5Y Avg
0.60%
Market Cap
$4.69B
Operating Cash Flow Yield
4.64%
TTM Avg
5.45%
3Y Avg
3.91%
5Y Avg
2.86%
Market Cap
$4.66B
Operating Cash Flow Yield
N/A
TTM Avg
5.97%
3Y Avg
5.97%
5Y Avg
5.97%
Market Cap
$5.13B
Operating Cash Flow Yield
5.52%
TTM Avg
6.10%
3Y Avg
4.38%
5Y Avg
3.97%
Market Cap
$5.11B
Operating Cash Flow Yield
N/A
TTM Avg
4.29%
3Y Avg
4.29%
5Y Avg
4.29%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.80B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | N/A | 0.78% | 0.73% | 0.73% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.99B | 0.91% | 0.60% | 0.60% | 0.60% |
| Erasca, Inc. (ERAS)vs › | $4.99B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 4.64% | 5.45% | 3.91% | 2.86% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.66B | N/A | 5.97% | 5.97% | 5.97% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.13B | 5.52% | 6.10% | 4.38% | 3.97% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.11B | N/A | 4.29% | 4.29% | 4.29% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
